All News

Pharmaceutical Representative

Widely prescribed pain killers that provide relief with minimal side effects may have more pain-relieving properties than previously identified. A new study funded by the National Institute of Neurological Disorders and Stroke shows that non-steroidal anti-inflammatory drugs not only relieve pain at the local site of inflammation, but in fact affect the entire central nervous system.

Pharmaceutical Representative

The National Institute on Drug Abuse and several national organizations have announced a public health initiative to raise awareness about recent trends in the misuse and abuse of prescription drugs in the United States.

Pharmaceutical Representative

The Society of Pharmaceutical and Biotech Trainers is the key organization to help representatives and managers interested in such a career path.

Pharmaceutical Representative

The language of sales is not so much about what is said, but rather what the customer hears and believes.

Pharmaceutical Representative

Sen. Jim Jeffords (R-VT) has introduced the Relief, Equity, Access and Coverage for Health Act, a bill that would provide refundable tax credits and other measures designed to reduce the number of uninsured and make health insurance more affordable for millions of low- and moderate-income working Americans.

Pharmaceutical Representative

While hospitals and physicians are using new-found bargaining clout to win payment increases from health plans, increased consumer demand fueled by the managed care backlash is hampering health plans' cost-control efforts, according to initial findings from the Washington-based Center for Studying Health System Change's latest round of community site visits.

Pharmaceutical Representative

Pharmaceutical meetings and events continue to grow as integral elements in overall promotion of prescription drugs, according to Newtown, PA-based Scott-Levin's "Physician Meeting & Event Audit," a survey of more than 3,400 doctors. The survey found that pharmaceutical companies spent $1.9 billion on events for physicians in 2000, 14% more than in 1999.

Pharmaceutical Representative

New products for rheumatoid arthritis patients are expected to dramatically improve the treatment of this condition, but will also dramatically raise the cost of treatment, according to a new report by New York-based Datamonitor. The report also found that changes in the treatment of RA will cause therapy to begin earlier, to last longer and to be administered as combinations of drugs rather than monotherapies. The result of such changes will be a dramatic increase in the cost of RA treatment overall, increasing the strain on healthcare budgets.

Pharmaceutical Executive

PMs find new ground for reinforcing marketing messages and targeting the media mix.

Pharmaceutical Executive

Everything you wanted to know from your customers and are ready to ask.

Pharmaceutical Executive

London-Government and industry have agreed there should be no weakening of patent protection in the effort to speed access to medicines in the developing world.

Pharmaceutical Executive

Grass never grew under her feet. She steadily rose to the top from the ranks of her industry. Now one of a handful of executive vice-presidents on the chairman's own management team, she co-directs the most important unit in the Pharmacia corporation, prescription pharmaceuticals, holding the title of president in that business.

Pharmaceutical Executive

Pharmaceutical executives should study their own scientists. They construct clever tools to explore convoluted phenomena. They are the true friends of complexity.

Pharmaceutical Executive

Planning fundamentals map the route to increased worldwide market share.

Pharmaceutical Executive

To work well together, product managers and their R&D liaisons must understand each other}s needs, motives, terminology, and decision processes.

Pharmaceutical Executive

Creative partnerships need realistic expectations and clear communication for successful product launch...and beyond.

Pharmaceutical Executive

Companies that fail to comply with regulatory guidelines make easy targets for investigators.

Pharmaceutical Executive

A new task force will examine European pharma}s competitiveness, innovation, and commitment to public health. The "G10" is not, as it may sound, an enlarged grouping of the world}s leading industrialized countries. It}s actually far more important than that.

Pharmaceutical Executive

Companies Face Costly System Overhauls With New FDA Regulations

Pharmaceutical Executive

PMs must think strategically, set objectives, and be responsible for the overall management of a product}s life cycle.

Pharmaceutical Executive

Rules imposed by FDA and other regulatory agencies add legal challenges to promoting pharmaceuticals.

Pharmaceutical Representative

Good territory and time management is the foundation of all successful selling, and successful territory and time management involves thorough knowledge of your territory.

Pharmaceutical Representative

Television is now the most widely used medium for direct-to-consumer pharmaceutical advertising, according to the latest study conducted by Market Measures Interactive, Livingston, NJ. In 2000, TV accounted for $949.5 million, 62% of all DTC ad dollars, up from the 57% of DTC budgets directed to TV in 1999. The rise in TV spending contrasts with a noticeable decline in DTC dollars directed to print media, including magazines and newspapers. As of September 2000, print media were attracting only 36% of DTC dollars - a drop from the 42% spent on DTC print ads in 1999.